FDA.reportPublic FDA data

Tukysa 50 MG Oral Tablet

RxCUI
2361300
RxNorm name
Tukysa 50 MG Oral Tablet
Display name
Tukysa 50 MG Oral Tablet
Full name
Tukysa 50 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TUKYSATUCATINIBSEAGEN INC.f27eb1b9-b7fc-424e-988f-84dd7bb195a32024-11-04Warnings, Adverse reactionsExact identifier
rxcui: 2361300

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f27eb1b9-b7fc-424e-988f-84dd7bb195a3TUKYSA 50 MG Oral Tablet [PSN] · tucatinib 50 MG Oral Tablet [Tukysa] [SBD] · Tukysa 50 MG Oral Tablet [SY]39These highlights do not include all the information needed to use TUKYSA safely and effectively. See full prescribing information for TUKYSA. TUKYSA ® (tucatinib) tablets, for oral use Initial U.S. Approval: 202020241104